Vidofludimus is an orally administered small-molecule compound and an investigational new drug. Its calcium salt is being evaluated to treat multiple sclerosis (MS), ulcerative colitis and other chronic inflammatory and autoimmune diseases.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.